Zenapax Related Clinical Trials
Human Anti-Tac (Daclizumab) to Treat JIA-Associated Uveitis [Completed]
Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis [Active, not recruiting]
ANTI-TAC THERAPY FOR UVEITIS [Completed]
Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk [Completed]
Zenapax to Treat Multiple Sclerosis [Active, not recruiting]
Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis [Completed]
A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients [Completed]
Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease [Active, not recruiting]
Daclizumab and Sirolimus to Treat Uveitis [Active, not recruiting]
Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis [Completed]
Combination Daclizumab/Denileukin Diftitox to Treat Uveitis [Completed]
Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis [Completed]
A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure [Recruiting]
Daclizumab to Treat Wegener's Granulomatosis [Completed]
Daclizumab to Treat HIV-Infected Patients [Completed]
To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris [Active, not recruiting]
Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients [Recruiting]
Daclizumab to Treat Chronic Immune Thrombocytopenia [Completed]
New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial [Active, not recruiting]
Study of Daclizumab in Patients With Chronic, Persistent Asthma [Completed]
Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery [Recruiting]
A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS) [Completed]
MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients [Completed]
Daclizumab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia [Recruiting]
A Trial of Two Daclizumab Dosing Strategies Vs. No Induction Treatment With Tacrolimus, MMF, & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients [Completed]
The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation [Completed]
Daclizumab in Treating Patients With Adult T-Cell Leukemia/Lymphoma [Recruiting]
Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation [Completed]
Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD [Recruiting]
Efficacy Study of Zenapax in Combination With CellCept, Cyclosporine and Corticosteroids in Heart Transplant [Completed]
Safety and Efficacy Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis [Recruiting]
Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration [Recruiting]
Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac [Completed]
Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk [Completed]
Daclizumab Experience in Pediatric Heart Transplant [Active, not recruiting]
To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris [Active, not recruiting]
Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation [Completed]
Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Active, not recruiting]
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients [Recruiting]
Suppressing the Immune System With or Without Steroids in Children Who Have Received Kidney Transplants [Active, not recruiting]
HAT in Eye Complications of Behcet's Disease [Completed]
Study Evaluating Sirolimus in Kidney Transplant Recipients [Active, not recruiting]
Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-Optimal Grafts [Completed]
Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma [Active, not recruiting]
Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-Severe Ulcerative Colitis [Active, not recruiting]
Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation [Active, not recruiting]
Monoclonal Antibody Therapy in Treating Patients With Leukemia [Completed]
Radiolabeled Monoclonal Antibody Therapy in Treating Adult Patients Who Have Recurrent Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma [Recruiting]
Comparison of Alemtuzumab/Tacrolimus Versus Interleukin-2 Receptor (IL-2R) Monoclonal Antibody (MoAb)/Tacrolimus/Mycophenolate in Kidney Transplantation [Active, not recruiting]
Prevention of Diabetes Progression Trial (PDPT) [Completed]
B-Lymphocyte Immunotherapy in Islet Transplantation [Recruiting]
Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis [Recruiting]
Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol [Recruiting]
Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.
Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch [Recruiting]
Islet Transplantation in Type 1 Diabetes [Recruiting]
Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection [Active, not recruiting]
Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA) [Not yet recruiting]
Strategies to Improve Islet Survival [Recruiting]
Fibrosis in Renal Allografts [Recruiting]
Differences in Genes and Proteins in Active and Controlled Uveitis [No longer recruiting]
Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression
Islet Cell Transplants for Diabetes [Active, not recruiting]
Pediatric Kidney Transplant Without Calcineurin Inhibitors [Active, not recruiting]
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes [Active, not recruiting]
Immunotoxin in Treating Patients With Leukemia or Lymphoma [Completed]
Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma [Completed]
Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes [Completed]
Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes [Recruiting]
LEA29Y (Belatacept) Emory Edmonton Protocol [Not yet recruiting]
Multipeptide Vaccine for Advanced Breast Cancer [Recruiting]
LMB-2 Immunotoxin in Treating Patients With Recurrent or Refractory Hairy Cell Leukemia [Recruiting]
LMB-2 Immunotoxin in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia [Recruiting]
LMB-2 Immunotoxin in Treating Patients With Cutaneous T-Cell Lymphoma [Recruiting]
Multicenter Uveitis Steroid Treatment (MUST) Trial [Recruiting]
Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys [Active, not recruiting]
Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen [Completed]
Kidney Transplantation in Patients With Cystinosis [Recruiting]
Steroid-Free and Long-Term Calcineurin-Free Trial in Islet Cell Transplantation [Recruiting]
Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen [Recruiting]
Phase I Thymus Transplantation With Immunosuppression [Recruiting]
|
